Viromed Medical DB:VMED Stock Report

Last Price

€2.46

Market Cap

€47.8m

7D

-1.6%

1Y

n/a

Updated

30 Dec, 2024

Data

Company Financials +

Viromed Medical AG

DB:VMED Stock Report

Market Cap: €47.8m

VMED Stock Overview

Engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. More details

VMED fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€48M)

My Notes

Capture your thoughts, links and company narrative

Viromed Medical AG Competitors

Geratherm Medical

XTRA:GME

€18.8m

NanoRepro

XTRA:NN6

€17.6m

PULSION Medical Systems

MUN:PUS

€131.1m

Audientes

DB:AUG

€6.9m

Price History & Performance

Summary of share price highs, lows and changes for Viromed Medical
Historical stock prices
Current Share Price	€2.46
52 Week High	€3.30
52 Week Low	€1.80
Beta	0
1 Month Change	14.95%
3 Month Change	25.51%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	14.95%

Recent News & Updates

Recent updates

Shareholder Returns

	VMED	DE Medical Equipment	DE Market
7D	-1.6%	-1.6%	0.3%
1Y	n/a	-9.1%	6.9%

Return vs Industry: Insufficient data to determine how VMED performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how VMED performed against the German Market.

Price Volatility

Is VMED's price volatile compared to industry and market?
VMED volatility
VMED Average Weekly Movement	14.6%
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: VMED's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine VMED's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	n/a	www.viromed-medical-ag.de

Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.

Viromed Medical AG Fundamentals Summary

How do Viromed Medical's earnings and revenue compare to its market cap?
VMED fundamental statistics
Market cap	€47.79m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is VMED overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VMED income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did VMED perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 05:10
End of Day Share Price	2024/12/30 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Viromed Medical AG is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Oliver Wojahn	mwb research AG